Signaling Activation and Modulation in Extrafollicular B Cell Responses
Immunological Reviews · 2025-03 · 330 (1)
DOI: 10.1111/imr.70004 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Immunological Reviews, online erschienen am 07.02.2025. Verfasst von Julian Staniek und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rheumatology and Clinical Immunology, Faculty of Medicine, University Medical Center Freiburg, University of Freiburg, Freiburg, German…. Hauptthemen laut MEDLINE: Signal Transduction, B-Lymphocytes, Germinal Center. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 218 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deutsche Forschungsgemeinschaft.
Abstract (Originalsprache)
The differentiation of naive follicular B cells into either the germinal center (GC) or extrafollicular (EF) pathway plays a critical role in shaping the type, affinity, and longevity of effector B cells. This choice also governs the selection and survival of autoreactive B cells, influencing their potential to enter the memory compartment. During the first 2–3 days following antigen encounter, initially activated B cells integrate activating signals from T cells, Toll‐like receptors (TLRs), and cytokines, alongside inhibitory signals mediated by inhibitory receptors. This integration modulates the intensity of signaling, particularly of the PI3K/AKT/mTOR pathway, which plays a central role in guiding developmental decisions. These early signaling events determine whether B cells undergo GC maturation or differentiate rapidly into antibody‐secreting cells (ASCs) via the EF pathway. Dysregulation of these signaling pathways—whether through excessive activation or defective regulatory mechanisms—can disrupt the balance between GC and EF fates, predisposing individuals to autoimmunity. Accordingly, aberrant PI3K/AKT/mTOR signaling has been implicated in the defective selection of autoreactive B cells, increasing the risk of autoimmune disease. This review focuses on the signaling events in newly activated B cells, with an emphasis on the induction and regulation of the PI3K/AKT/mTOR pathway. It also highlights gaps in our understanding of how alternative B cell fates are regulated. Both the physiological context and the implications of inborn errors of immunity (IEIs) and complex autoimmune conditions will be discussed in this regard.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Rheumatology and Clinical Immunology, Faculty of Medicine, University Medical Center Freiburg, University of Freiburg, Freiburg, Germany.
- Faculty of Medicine, Center for Chronic Immunodeficiency, University Medical Center Freiburg, University of Freiburg, Freiburg, Germany.
- Division of Clinical and Experimental Immunology, Institute of Immunology, Center for Pathophysiology, Infectiology and Immunology, Medical University of Vienna, Vienna, Austria.
- CIBSS-Centre for Integrative Biological Signalling Studies, University of Freiburg, Freiburg, Germany.
ORCID-Profile: Marta Rizzi
Förderung
- Deutsche Forschungsgemeinschaft
Zitieren
APA
Staniek, J., & Rizzi, M. (2025). Signaling Activation and Modulation in Extrafollicular B Cell Responses. Immunological Reviews, 330(1). https://doi.org/10.1111/imr.70004
Vancouver
Staniek J, Rizzi M. Signaling Activation and Modulation in Extrafollicular B Cell Responses. Immunological Reviews. 2025;330(1). doi:10.1111/imr.70004
BibTeX
@article{Staniek2025,
author = {Staniek, Julian and Rizzi, Marta},
title = {Signaling Activation and Modulation in Extrafollicular B Cell Responses},
journal = {Immunological Reviews},
year = {2025},
volume = {330},
number = {1},
doi = {10.1111/imr.70004}
}
EUVIMED